Hostname: page-component-8448b6f56d-cfpbc Total loading time: 0 Render date: 2024-04-23T16:42:10.496Z Has data issue: false hasContentIssue false
  • English
  • Français

Environmental Risk Factors for Parkinson's Disease: The Epidemiologic Evidence

Published online by Cambridge University Press:  05 January 2016

Bruce S. Schoenberg
Bruce S. Schoenberg*
Affiliation:
Neuroepidemiology Branch, Intramural Research Program, National Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, Maryland and the Department of Neurology, Georgetown, University School of Medicine, Washington, D.C.
*
Medical Liaison Service, Sandoz Canada Inc., P.O. Box 385. Dorval, Quèbec, Canada H9R 4P5
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Descriptive data from several studies suggest variations in the frequency of Parkinson's disease in different population groups. Door-to-door surveys were carried out among a biracial U.S. population (blacks and whites) and in communities in Nigeria and the People's Republic of China. The U.S. investigation revealed no substantial differences in the age-adjusted prevalence ratios by race. However, blacks in Nigeria have a much lower prevalence ratio than blacks in the U. S., suggesting an environmental etiologic factor. Prevalence ratios derived from China are also lower than the U.S. figures. Studies of temporal trends in the incidence rates in one U.S. population (Rochester, Minnesota) show virtually no change over 35 years, indicating that the primary cause(s) of Parkinson's disease must have been present in this nonindustrialized community for many years. Analytic studies generally reveal an inverse association between Parkinson's disease and cigarette smoking, although epidemiologic evidence does not support a direct protective effect of smoking. Preliminary investigations suggest an increased risk associated with the rural environment and the consumption of well water. Further studies are required to discover as yet unknown environmental factors that heighten the risk of Parkinson's disease.

Type
Research Article
Information
Canadian Journal of Neurological Sciences , Volume 14 , Issue S3 , August 1987 , pp. 407 - 413
Copyright
Copyright © Canadian Neurological Sciences Federation 1987

References

REFERENCES

1.Schoenberg, BS.Principles of neurological epidemiology. In: Schoenberg, BS, ed. Advances in Neurology, vol. 19, Neurological Epidemiology: Principles and Clinical Applications. New York: Raven Press, 1978: 11–54.Google Scholar
2.Chandra, V, Bharucha, NE, Schoenberg, BS.Mortality data for the U .S. for deaths due to and related to twenty neurologic diseases. Neuroepidemiology 1984:3: 149–168.CrossRefGoogle Scholar
3.Duvoisin, RC, Schweitzer, MD.Paralysis agitans mortality in England and Wales, 1855–1962. Br J Prev Med 1966; 20: 27–33.Google Scholar
4.Kurtzke, JF, Kurland, LT.The epidemiology of neurologic disease. In: Baker, AB, Baker, LH, eds. Clinical Neurology, vol. 4, chapter 66. Philadelphia: Harper and Row, 1983: 55–60.Google Scholar
5.De Pedro Cuesta, J.Thesis: Studies on the Prevalence of Paralysis AgitansbyTracerMethodology. Huddinge, Sweden: Karolinska Institute, 1986: 19–84.Google Scholar
6.Broman, T.Parkinson’s syndrome, prevalence and incidence in Goteborg. Acta Neurol Scand 1963; 39. Suppl. 4: 95–101.CrossRefGoogle Scholar
7.Brewis, M, Poskanzer, DC, Rolland, C, et al. Neurological disease in an English city. Acta Neurol Scand 1966; 42, Suppl. 24.Google Scholar
8.Gudmundsson, KR.A clinical survey of parkinsonism in Iceland. Acta Neurol Scand 1967; 43, Suppl. 33: 9–61.CrossRefGoogle ScholarPubMed
9.Kurland, LT, Hauser, WA, Okazaki, H, et al. Epidemiologic studies of parkinsonism with special reference to the cohort hypothesis. In: Gillingham, FJ, Donaldson, JM, eds. Proceedings of the Third Symposiumon Parkinsonism. Edinburgh: E. andS. Livingstone, 1969: 12–16.Google Scholar
10.Jenkins, AC.Epidemiology of parkinsonism in Victoria. Med J Aust 1966; 2: 496–502.CrossRefGoogle ScholarPubMed
11.Marttila, RJ, Rinne, UK.Epidemiology of Parkinson’s disease in Finland. Acta Neurol Scand 1976; 53: 81–102.Google ScholarPubMed
12.Kessler, II.Epidemiologic studies of Parkinson’s disease. III. A community based survey. Am J Epidemiol 1972; 96: 242–254.CrossRefGoogle Scholar
13.Schoenberg, BS, Anderson, DW, Haerer, AF.Prevalence of Parkinson’s disease in the biracial population of Copiah County, Mississippi. Neurology 1985; 35: 841–845.CrossRefGoogle ScholarPubMed
14.Harada, H, Nishikawa, S,Takahashi, K.Epidemiology of Parkinson’s disease in a Japanese city. Arch Neurol 1983; 40: 151–154.CrossRefGoogle Scholar
15.Li, SC, Schoenberg, BS, Wang, CC.et al. A prevalence survey of Parkinson’s disease and other movement disorders in the People’s Republic of China. Arch Neurol 1985; 42: 655–657.CrossRefGoogle ScholarPubMed
16.Kessler, II.Parkinson’s disease in epidemiologic perspective. In: Schoenberg, BS, ed. Advances in Neurology, vol. 19, Neurological Epidemiology: Principles and Clinical Applications. New York: Raven Press, 1978: 355–384.Google Scholar
17.Kurland, LT, Molgaard, CA.The patient record in epidemiology. Sci Am 1981; 245: 54–63.CrossRefGoogle ScholarPubMed
18.Kurland, LT, Molgaard, CA, Schoenberg, BS.Mayo Clinic recordslinkage: contributions to neuroepidemiology. Neuroepidemiology 1982; 1: 102–114.CrossRefGoogle Scholar
19.Schoenberg, BS, Osuntokun, BO, Adeuja, AOG. et al. Abstract: Comparison of the prevalence of Parkinson’s disease in the rural U.S. and in rural Nigeria: door-to-door community studies. Neurology, in press.Google Scholar
20.Schoenberg, BS.Clinical neuroepidemiology in developing countries: Neurology with few neurologists. Neuroepidemiology 1982; 1: 137–142.CrossRefGoogle Scholar
21.Schoenberg, BS.Neuroepidemiologic generalizations: High tax on importing data, low tax on importing principles. Neuroepidemiology 1983:2: 117–120.CrossRefGoogle Scholar
22.Barbeau, A, Roy, M, Cloutier, T, et al. Environmental and genetic factors in the etiology of Parkinson’s disease. In: Yahr, MD, ed. Proceedings of the VIII International Symposium on Parkinson’s Disease. New York: Raven Press, in press.Google Scholar
23.Lewin, R.Parkinson’s disease: An environmental cause? Science 1985; 229: 257–258.CrossRefGoogle ScholarPubMed
24.Calne, DB.Langston, JW.Aetiology of Parkinson’s disease. Lancet 1983; 2: 1457–1459.CrossRefGoogle ScholarPubMed
25.Rajput, AH, Offord, KP.Beard, CM, et al. Epidemiology of parkinsonism: Incidence, classification, and mortality. Ann Neurol 1984; 16: 278–282.CrossRefGoogle ScholarPubMed
26.Kurland, LT, Kurtzke, JF.Goldberg, ID, et al. Parkinsonism. In: Kurland, LT, Kurtzke, JF.Goldberg, ID, eds. Epidemiology of Neurologic and Sense Organ Disorders. Cambridge, Massachusetts: Harvard University Press, 1973: 41–63.Google Scholar
27.Hammond, EC.Smoking in relation to the death rates of one million men and women. In Epidemiological Study of Cancer and Other Chronic Diseases, National Cancer Institute Monograph 19. Washington, D.C.: U.S. Government Printing Office. 1966: 127–204.Google Scholar
28.Kahn, HA.The Dom study of smoking and mortality among U.S. veterans; report on eight and one-half years of observation. In Epidemiologic Approaches to the Study of Cancer and Other Chronic Diseases, National Cancer Institute Monograph 19. Washington, D.C.: U.S. Government PrintingOffice, 1966:1–125.Google Scholar
29.Nefzger, MD, Quadfasel, FA, Kark, VC.A retrospective study of smoking in Parkinson’s disease. Am J Epidemiol 1968:88:149–158.CrossRefGoogle ScholarPubMed
30.Kessler, II.Diamond, EL.Epidemiologic studies of Parkinson’s disease. I. Smoking and Parkinson’s disease: A survey and explanatory hypothesis. Am J Epidemiol 1971: 94: 16–25.CrossRefGoogle ScholarPubMed
31.Marttila, RJ, Rinne, UK.Smoking and Parkinson’s disease. Acta Neurol Scand 1980; 62: 322–325.CrossRefGoogle ScholarPubMed
32.Baumann, RJ, Jameson, HD, Mckean, HE.et al. Cigarette smoking and Parkinson’s disease. I. A comparison of cases with matched neighbors. Neurology 1980; 30: 839–843.CrossRefGoogle Scholar
33.Haack, DG, Baumann, RJ, Mckean, HE, et al. Nicotine exposure and Parkinson’s disease. Am J Epidemiol 1981; 114: 191–200.CrossRefGoogle Scholar
34.Ward, CD, Duvoisin, RC, Ince, SE, et al. Parkinson’s disease in 65 pairs of twins and in a set of quadruplets. Neurology 1983; 33: 815–825.CrossRefGoogle Scholar
35.Bharucha, NE, Stokes, L, Schoenberg, BS, et al. A case-control study of twin pairs discordant for Parkinson’s disease: A search for environmental risk factors. Neurology 1986: 36: 284–288.CrossRefGoogle ScholarPubMed
36.Rajput, AH.Epidemiology of Parkinson’s disease. Can J Neurol Sci 1984; 2, Suppl. 1; 156–160.CrossRefGoogle Scholar
37.Todes, CJ, Lees, AJ.The pre-morbid personality of patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 1985; 48; 97–100.CrossRefGoogle ScholarPubMed
38.Eldridge, R, Rocca, WA.Parkinson disease: Etiologic considerations. In: King, RA, Rotter, Jl, Motulsky, AG, eds. The Genetic Basis of Common Disease. New York: McGraw-Hill, in press.Google Scholar
39.Duvoisin, RC, Eldridge, R, Williams, A, et al. Twin study of Parkin- son disease. Neurology 1981; 31: 77–80.CrossRefGoogle Scholar
40.Rajput, AH, Stern, W, Christ, A, et al. Abstract: Etiology of Parkinson’s disease: environmental factors. Neurology 1984; 34, Suppl. 1: 207.Google Scholar
41.Tanner, CM.Abstract: Well waterdrinkingand Parkinson’s disease. Abstracts of the VIII International Symposium on Parkinson’s Disease. New York: World Federation of Neurology Research Group on Extrapyramidal Diseases, 1985: 11.Google Scholar
42.Marttila, RJ, Rinne, U.Herpes simplex virus antibodies in patients with Parkinson’s disease. J Neurol Sci 1978; 35: 375–379.CrossRefGoogle ScholarPubMed
43.Elizan, TS, Madden, DL, Noble, GR, et al. Viral antibodies in serum and CSF of parkinsonian patients and controls. Arch Neurol 1979; 36: 529–534.CrossRefGoogle ScholarPubMed
44.Wetmore, JG, Schwartz, J, Elizan, T.Nucleic acid homology studies of viral nucleic acid in idiopathic Parkinson’s disease. Arch Neurol 1979; 36: 462–498.CrossRefGoogle Scholar
45.Sasco, AJ, Paffenbarger, RS Jr. Measles infection and Parkinson’s disease. Am J Epidemiol 1985; 122: 1017–1031.CrossRefGoogle ScholarPubMed
46.Marttila, RJ, Rinne, UK.Arteriosclerosis, heredity and some previous infections in the etiology of Parkinson’s disease. A case-control study. Clin Neurol Neurosurg 1977; 79: 46–56.CrossRefGoogle Scholar
47.Poskanzer, DC, Schwab, RS.Cohort analysis of Parkinson’s disease: evidence for a single etiology related to sub-clinical infection about 1920. J Chronic Dis 1963: 16: 961–973.CrossRefGoogle Scholar
48.Geraghty, JJ, Jankovic, J, Zetusky, WJ.Association between essential tremor and Parkinson’s disease. Ann Neurol 1985; 329–333.CrossRefGoogle ScholarPubMed
49.Jansson, B, Jankovic, J.Low cancer rates among patients with Parkinson’s disease. Ann Neurol 1985; 17: 505–509.CrossRefGoogle ScholarPubMed
50.Godwin-Austen, RB, Lee, PN, Marmot, MG, et al. Smoking and Parkinson’s disease. J Neurol Neurosurg Psychiatry 1982; 45: 577–581.CrossRefGoogle ScholarPubMed
51.Burns, RS, Lewitt, PA, Pakkenberg, H, et al. The clinical syndrome of striatal dopamine deficiency: MPTP-induced parkinsonism.? Engl J Med 1985; 312: 1418–1421.CrossRefGoogle Scholar
52.Snyder, SH.Clues to aetiology of Parkinson’s disease from a toxin. Nature 1984; 311: 514–515.CrossRefGoogle ScholarPubMed
53.Barbeau, A, Roy, M, Paris, S, et al. Ecogenetics of Parkinson’s disease: 4-hydroxylation of debrisoquine. Lancet 1985; 2: 1213–1215.CrossRefGoogle ScholarPubMed
54.Eldridge, R, Rocca, WA, Ince, SE.Parkinson’s disease: Evidence against toxic etiology and for an alternative theory. In: Markey, SP, Castagnoli, N, Trevor, AJ, Kopin, IJ, eds. MPTP: A Neurotoxin Producing A Parkinsonian Syndrome. New York: Academic Press, 1986: 355–367.Google Scholar